User login
Improving Veteran Health Care with Regional Health Information Organizations
Determining Efficacy of Antibacterial Hand Wash Products
Determining Efficacy of Antibacterial Hand Wash Products
This promotional supplement was supported by American Cleaning Institute® and the Personal Care Products Council.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
- 1994 FDA-Proposed Antiseptic Hand Wash Efficacy Criteria
- Need for Link Between Bacterial Log Reduction and Disease
- New Model for Efficacy Evaluation of Antibacterial Hand Washes
- New Scientific Model Links Bacterial Reduction with Reduction in Disease
- Expert Panel Review of the New Model for Efficacy Evaluation
- Expert Panel Consensus Statement
- Expanding the Scope of the New Scientific Model to Other Health Care Settings
- Moving Forward
Francis H. Kruszewski, PhD, DABT
Director, Human Health and Safety
American Cleaning Institute® (formerly the Soap and Detergent Association)
Washington, DC
Francis H. Kruszewski, PhD, DABT is employed by American Cleaning Institute® (formerly the Soap and Detergent Association)
John F. Krowka, PhD
Senior Environmental Scientist
The Personal Care Products Council
Washington, DC
John F. Krowka, PhD is employed by The Personal Care Products Council
Copyright © 2011 Elsevier Inc.
Determining Efficacy of Antibacterial Hand Wash Products
This promotional supplement was supported by American Cleaning Institute® and the Personal Care Products Council.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
- 1994 FDA-Proposed Antiseptic Hand Wash Efficacy Criteria
- Need for Link Between Bacterial Log Reduction and Disease
- New Model for Efficacy Evaluation of Antibacterial Hand Washes
- New Scientific Model Links Bacterial Reduction with Reduction in Disease
- Expert Panel Review of the New Model for Efficacy Evaluation
- Expert Panel Consensus Statement
- Expanding the Scope of the New Scientific Model to Other Health Care Settings
- Moving Forward
Francis H. Kruszewski, PhD, DABT
Director, Human Health and Safety
American Cleaning Institute® (formerly the Soap and Detergent Association)
Washington, DC
Francis H. Kruszewski, PhD, DABT is employed by American Cleaning Institute® (formerly the Soap and Detergent Association)
John F. Krowka, PhD
Senior Environmental Scientist
The Personal Care Products Council
Washington, DC
John F. Krowka, PhD is employed by The Personal Care Products Council
Copyright © 2011 Elsevier Inc.
Determining Efficacy of Antibacterial Hand Wash Products
This promotional supplement was supported by American Cleaning Institute® and the Personal Care Products Council.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
- 1994 FDA-Proposed Antiseptic Hand Wash Efficacy Criteria
- Need for Link Between Bacterial Log Reduction and Disease
- New Model for Efficacy Evaluation of Antibacterial Hand Washes
- New Scientific Model Links Bacterial Reduction with Reduction in Disease
- Expert Panel Review of the New Model for Efficacy Evaluation
- Expert Panel Consensus Statement
- Expanding the Scope of the New Scientific Model to Other Health Care Settings
- Moving Forward
Francis H. Kruszewski, PhD, DABT
Director, Human Health and Safety
American Cleaning Institute® (formerly the Soap and Detergent Association)
Washington, DC
Francis H. Kruszewski, PhD, DABT is employed by American Cleaning Institute® (formerly the Soap and Detergent Association)
John F. Krowka, PhD
Senior Environmental Scientist
The Personal Care Products Council
Washington, DC
John F. Krowka, PhD is employed by The Personal Care Products Council
Copyright © 2011 Elsevier Inc.
Antiplatelet Therapy: Role of Effient® (prasugrel)
A Best Practices supplement to Internal Medicine News. This promotional supplement was supported by Daiichi-Sankyo, Inc. and Eli Lilly and Company.
Antiplatelet Therapy: Role of Effient® (prasugrel)
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
- Introduction
- Clinical Pharmacology
- TRITON-TIMI 38
- Bleeding
- Application of TRITON-TIMI 38 to Clinical Practice
- Conclusion
- Effient Important Safety Information
Roxana Mehran, MD
Director of Interventional Cardiovascular Research and Clinical Trials
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Chief Scientific Officer
Clinical Trials Center
Cardiovascular Research Foundation
New York, NY
Dr Mehran receives grant support from sanofi-aventis/Bristol-Myers Squibb and is a consultant for Abbott Vascular, Accumetrics, Cardiva, and The Medicines Company and is a paid consultant to Daiichi Sankyo, Inc. and Lilly USA, LLC.
Benjamin Z. Galper, MD, MPH
Medical Resident
Department of Medicine
New York Presbyterian Hospital/Columbia University Medical Center
New York, NY
Dr Galper is a paid consultant of Daiichi Sankyo, Inc. and Lilly USA, LLC.
George D. Dangas, MD, PhD
Director of Cardiovascular Innovation
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Director, Academic Affairs
Cardiovascular Research Foundation
New York, NY
Dr Dangas is a consultant for AstraZeneca and Cordis Corp. (a Johnson & Johnson Company) and a paid consultant to
Daiichi Sankyo, Inc. and Lilly USA, LLC.
Copyright © 2010 Elsevier Inc.
A Best Practices supplement to Internal Medicine News. This promotional supplement was supported by Daiichi-Sankyo, Inc. and Eli Lilly and Company.
Antiplatelet Therapy: Role of Effient® (prasugrel)
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
- Introduction
- Clinical Pharmacology
- TRITON-TIMI 38
- Bleeding
- Application of TRITON-TIMI 38 to Clinical Practice
- Conclusion
- Effient Important Safety Information
Roxana Mehran, MD
Director of Interventional Cardiovascular Research and Clinical Trials
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Chief Scientific Officer
Clinical Trials Center
Cardiovascular Research Foundation
New York, NY
Dr Mehran receives grant support from sanofi-aventis/Bristol-Myers Squibb and is a consultant for Abbott Vascular, Accumetrics, Cardiva, and The Medicines Company and is a paid consultant to Daiichi Sankyo, Inc. and Lilly USA, LLC.
Benjamin Z. Galper, MD, MPH
Medical Resident
Department of Medicine
New York Presbyterian Hospital/Columbia University Medical Center
New York, NY
Dr Galper is a paid consultant of Daiichi Sankyo, Inc. and Lilly USA, LLC.
George D. Dangas, MD, PhD
Director of Cardiovascular Innovation
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Director, Academic Affairs
Cardiovascular Research Foundation
New York, NY
Dr Dangas is a consultant for AstraZeneca and Cordis Corp. (a Johnson & Johnson Company) and a paid consultant to
Daiichi Sankyo, Inc. and Lilly USA, LLC.
Copyright © 2010 Elsevier Inc.
A Best Practices supplement to Internal Medicine News. This promotional supplement was supported by Daiichi-Sankyo, Inc. and Eli Lilly and Company.
Antiplatelet Therapy: Role of Effient® (prasugrel)
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
- Introduction
- Clinical Pharmacology
- TRITON-TIMI 38
- Bleeding
- Application of TRITON-TIMI 38 to Clinical Practice
- Conclusion
- Effient Important Safety Information
Roxana Mehran, MD
Director of Interventional Cardiovascular Research and Clinical Trials
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Chief Scientific Officer
Clinical Trials Center
Cardiovascular Research Foundation
New York, NY
Dr Mehran receives grant support from sanofi-aventis/Bristol-Myers Squibb and is a consultant for Abbott Vascular, Accumetrics, Cardiva, and The Medicines Company and is a paid consultant to Daiichi Sankyo, Inc. and Lilly USA, LLC.
Benjamin Z. Galper, MD, MPH
Medical Resident
Department of Medicine
New York Presbyterian Hospital/Columbia University Medical Center
New York, NY
Dr Galper is a paid consultant of Daiichi Sankyo, Inc. and Lilly USA, LLC.
George D. Dangas, MD, PhD
Director of Cardiovascular Innovation
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Director, Academic Affairs
Cardiovascular Research Foundation
New York, NY
Dr Dangas is a consultant for AstraZeneca and Cordis Corp. (a Johnson & Johnson Company) and a paid consultant to
Daiichi Sankyo, Inc. and Lilly USA, LLC.
Copyright © 2010 Elsevier Inc.
Program to Improve Prescribing of Primarily Renally Cleared Oral Medications in Older Veteran Community Living Center Patients
Culturally Sensitive, Senior-Friendly Health Information for Caregivers of Veterans With Stroke
The Driving Clinic: A Pilot Program for Veterans with Dementia
BEST PRACTICES IN: NSAIDS for Analgesia of Acute Pain
A supplement to Internal Medicine News. This supplement was supported by Wyeth.
•Topics
•Faculty/Faculty Disclosures
|
• Use of OTC Medication for Acute Pain
• Rationale for Ibuprofen Use in Acute Pain
• NSAID Side Effects
• More Attention to Dosage Recommendations Will Reduce Side Effects Risk
• OTC Ibuprofen Dosage Recommendations
• Conclusion
Faculty/Faculty Disclosure
Lee S. Simon, MD
Principal
SDG, LLC.
Cambridge, Mass.
Dr Simon previously served as the Division Director of the Arthritis, Analgesic & Ophthalmologic Drug Product Division at the US Food and Drug Administration Center for Drug Evaluation and Research. He is a Principal in SDG, LLC., a consulting company.
A supplement to Internal Medicine News. This supplement was supported by Wyeth.
•Topics
•Faculty/Faculty Disclosures
|
• Use of OTC Medication for Acute Pain
• Rationale for Ibuprofen Use in Acute Pain
• NSAID Side Effects
• More Attention to Dosage Recommendations Will Reduce Side Effects Risk
• OTC Ibuprofen Dosage Recommendations
• Conclusion
Faculty/Faculty Disclosure
Lee S. Simon, MD
Principal
SDG, LLC.
Cambridge, Mass.
Dr Simon previously served as the Division Director of the Arthritis, Analgesic & Ophthalmologic Drug Product Division at the US Food and Drug Administration Center for Drug Evaluation and Research. He is a Principal in SDG, LLC., a consulting company.
A supplement to Internal Medicine News. This supplement was supported by Wyeth.
•Topics
•Faculty/Faculty Disclosures
|
• Use of OTC Medication for Acute Pain
• Rationale for Ibuprofen Use in Acute Pain
• NSAID Side Effects
• More Attention to Dosage Recommendations Will Reduce Side Effects Risk
• OTC Ibuprofen Dosage Recommendations
• Conclusion
Faculty/Faculty Disclosure
Lee S. Simon, MD
Principal
SDG, LLC.
Cambridge, Mass.
Dr Simon previously served as the Division Director of the Arthritis, Analgesic & Ophthalmologic Drug Product Division at the US Food and Drug Administration Center for Drug Evaluation and Research. He is a Principal in SDG, LLC., a consulting company.
Diagnosis and Management of Alpha-1 Antitrypsin Deficiency
A supplement to Internal Medicine News. This supplement was supported by Talecris Biotherapeutics.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topics
•What is Alpha-1 Antitrypsin Deficiency?
•AAT Deficiency is Widely Underrecognized
•Why Are Rates of Diagnosis So Low?
•Optimal Diagnosis and Management Strategies
Faculty/Faculty Disclosures
Faculty/Faculty Disclosures
Leonard Fromer, MD
Assistant Clinical Professor, Family Medicine
David Geffen School of Medicine
University of California
Los Angeles
Dr. Fromer is a consultant for Talecris Biotherapeutics, Inc.
A supplement to Internal Medicine News. This supplement was supported by Talecris Biotherapeutics.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topics
•What is Alpha-1 Antitrypsin Deficiency?
•AAT Deficiency is Widely Underrecognized
•Why Are Rates of Diagnosis So Low?
•Optimal Diagnosis and Management Strategies
Faculty/Faculty Disclosures
Faculty/Faculty Disclosures
Leonard Fromer, MD
Assistant Clinical Professor, Family Medicine
David Geffen School of Medicine
University of California
Los Angeles
Dr. Fromer is a consultant for Talecris Biotherapeutics, Inc.
A supplement to Internal Medicine News. This supplement was supported by Talecris Biotherapeutics.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topics
•What is Alpha-1 Antitrypsin Deficiency?
•AAT Deficiency is Widely Underrecognized
•Why Are Rates of Diagnosis So Low?
•Optimal Diagnosis and Management Strategies
Faculty/Faculty Disclosures
Faculty/Faculty Disclosures
Leonard Fromer, MD
Assistant Clinical Professor, Family Medicine
David Geffen School of Medicine
University of California
Los Angeles
Dr. Fromer is a consultant for Talecris Biotherapeutics, Inc.
Chronic Inflammatory Demyelinating Polyradiculoneuropathy in the Internal Medicine Setting
A supplement to Internal Medicine News. This supplement was supported by Talecris Biotherapeutics.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topics
•Clinical Scenario
•Presenting Symptoms of CIDP
•Differential Diagnosis/Concomitant Conditions
•Obtaining a Diagnosis
•Therapeutic Options
•Best Practices: Key Takeaways
Faculty/Faculty Disclosures
Faculty/Faculty Disclosures
Peter Donofrio, MD
Department of Neurology
Vanderbilt University
Nashville, Tennessee
Dr. Donofrio is a consultant for the Steering Committee of the Talecris Biotherapeutics ICE Study.
A supplement to Internal Medicine News. This supplement was supported by Talecris Biotherapeutics.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topics
•Clinical Scenario
•Presenting Symptoms of CIDP
•Differential Diagnosis/Concomitant Conditions
•Obtaining a Diagnosis
•Therapeutic Options
•Best Practices: Key Takeaways
Faculty/Faculty Disclosures
Faculty/Faculty Disclosures
Peter Donofrio, MD
Department of Neurology
Vanderbilt University
Nashville, Tennessee
Dr. Donofrio is a consultant for the Steering Committee of the Talecris Biotherapeutics ICE Study.
A supplement to Internal Medicine News. This supplement was supported by Talecris Biotherapeutics.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topics
•Clinical Scenario
•Presenting Symptoms of CIDP
•Differential Diagnosis/Concomitant Conditions
•Obtaining a Diagnosis
•Therapeutic Options
•Best Practices: Key Takeaways
Faculty/Faculty Disclosures
Faculty/Faculty Disclosures
Peter Donofrio, MD
Department of Neurology
Vanderbilt University
Nashville, Tennessee
Dr. Donofrio is a consultant for the Steering Committee of the Talecris Biotherapeutics ICE Study.
The Effective Management of Chronic Constipation and IBS-C
A supplement to Internal Medicine News and supported by Takeda Pharmaceuticals North America, Inc.
To view the supplement, click the image above.
This supplement has been designed to meet the educational needs of clinicians relative to the diagnosis and effective management of chronic constipation and IBS-C.
Faculty
Harold Fields, MD
Founder, Village Family Practice
Houston, TX
Wendy Wright, MS, RN, ARNP, FNP, FAANP
Owner, Wright & Associates
Family Healthcare
Amherst, NH
A supplement to Internal Medicine News and supported by Takeda Pharmaceuticals North America, Inc.
To view the supplement, click the image above.
This supplement has been designed to meet the educational needs of clinicians relative to the diagnosis and effective management of chronic constipation and IBS-C.
Faculty
Harold Fields, MD
Founder, Village Family Practice
Houston, TX
Wendy Wright, MS, RN, ARNP, FNP, FAANP
Owner, Wright & Associates
Family Healthcare
Amherst, NH
A supplement to Internal Medicine News and supported by Takeda Pharmaceuticals North America, Inc.
To view the supplement, click the image above.
This supplement has been designed to meet the educational needs of clinicians relative to the diagnosis and effective management of chronic constipation and IBS-C.
Faculty
Harold Fields, MD
Founder, Village Family Practice
Houston, TX
Wendy Wright, MS, RN, ARNP, FNP, FAANP
Owner, Wright & Associates
Family Healthcare
Amherst, NH